MedPath

Dexmedetomidine to prevent Emergence delirium

Not Applicable
Conditions
Health Condition 1: F989- Unspecified behavioral and emotional disorders with onset usually occurring in childhood and adolescence
Registration Number
CTRI/2020/06/025744
Lead Sponsor
Vision Research Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All American Society of Anesthesiologists (ASA) Grade I, II. Age 3-12 yrs scheduled for ocular surgeries.

Exclusion Criteria

1. Emergency surgery

2. Children with intelectual disability

3. Children with neurological diseases

4. Renal or Hepatic disease

5. Children with cardiac or respiratory diseases

6. Allergy to Dexmedetomidine

7. Obese children

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of ED within 30 minutes after extubationTimepoint: Incidence of ED within 30 minutes after extubation
Secondary Outcome Measures
NameTimeMethod
The incidence of <br/ ><br>â?¢ Pain, <br/ ><br>â?¢ Extubation time, <br/ ><br>â?¢ Post-anesthesia care unit (PACU) length of stay after extubation, <br/ ><br>â?¢ Adverse events such as PONV, laryngospasm, severe coughing, oxygen desaturation and bradycardiaTimepoint: 7 months
© Copyright 2025. All Rights Reserved by MedPath